GTBPbenzinga

EXCLUSIVE: GT Biopharma Tells Benzinga 'The company plans on releasing more detailed results from Phase 1 later in 2025 following completion of additional dose cohorts'

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 19, 2025 by benzinga